| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8246807 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusions: The used amifostine doses were not able to reduce the toxicity of simultaneous radiochemotherapy for head-and-neck cancer. The safety of amifostine and the lack of tumor protection were consistent with previous studies.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jens M.D., Oliver M.D., Irenaus A. M.D., Alain M.D., Michael M.D., Alexander M.D.,